Skip to main content

Autoantibodies may help detect early-stage esophageal squamous cell carcinoma

Physicians may be able to accurately diagnose the eighth most common malignant disease and the sixth leading cause of cancer-related death worldwide in its early stages by measuring autoantibody response to multiple tumor-associated antigens, a study found.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino